1.28
price down icon5.19%   -0.07
pre-market  Pre-market:  1.30   0.02   +1.56%
loading

Fate Therapeutics Inc Stock (FATE) Forecast

The Fate Therapeutics Inc (FATE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.50, representing a +1,033% increase from the current price of $1.28. The highest analyst price target is $20.62, and the lowest is $8.38.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FATE Price Target
Average 59.82 (+4,574% Upside)
loading

Is Fate Therapeutics Inc (FATE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 60.95 Neutral
STOCH(9,6) 78.50 Neutral
STOCHRSI(14) 66.58 Neutral
MACD(12,26) 0.0898 Buy
ADX(14) 29.51 Buy
William %R -25.96 Neutral
CCI(14) 69.42 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.1844
Buy
1.197
Buy
MA20
1.0057
Buy
1.0998
Buy
MA50
1.0582
Buy
1.1301
Buy
MA100
1.3801
Sell
1.4727
Sell
MA200
2.4161
Sell
2.2976
Sell
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, FATE could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 4 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on FATE, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 60.95 indicates that FATE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 78.5 indicates that FATE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.58 indicates that FATE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 29.51 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 69.42 indicates that FATE is still overbought but not to an extreme extent.

Long-term FATE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Fate Therapeutics Inc financial reports and earnings history, Fate Therapeutics Inc (FATE) stock could reach $7.9123 by 2030, $10.22 by 2040 and $2.6927 by 2050. See the projected annual prices until 2050 of the Fate Therapeutics Inc stock below:

  • Fate Therapeutics Inc (FATE) is expected to reach an average price of $5.8264 in 2035, with a high prediction of $6.6225 and a low estimate of $5.8665. This indicates an $355.19% rise from the last recorded price of $1.28.
  • Fate Therapeutics Inc (FATE) stock is projected to chart a bullish course in 2040, with an average price target of $9.7304, representing an $660.19% surge from its current level. The forecast ranges from a conservative $9.949 to a sky-high $10.22.
  • Our analysts predict Fate Therapeutics Inc (FATE) to jump 224.50% by 2045, soaring from $1.5778 to an average price of $4.1536, potentially reaching $3.3822. While $1.5778 is the low estimate, the potential upside is significant.
  • Fate Therapeutics Inc (FATE) stock is expected to climb by 2050, reaching an average of $0.025, a $-98.04% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.6927 and $4.5727, respectively, highlighting the market's uncertainty.

Fate Therapeutics Inc Stock (FATE) Year by Year Forecast

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2025

Fate Therapeutics Inc Stock (FATE) is expected to reach an average price of $22.93 in 2025, with a high prediction of $40.72 and a low estimate of $5.1319. This indicates an +1,691% rise from the last recorded price of $1.28.
Month Average Low High Change from today's price
May, 2025 $19.02 $8.38 $20.62 +1,386%
June, 2025 $17.21 $14.36 $20.81 +1,245%
July, 2025 $20.61 $16.54 $26.07 +1,510%
August, 2025 $24.33 $19.72 $27.59 +1,801%
September, 2025 $23.04 $19.35 $25.21 +1,700%
October, 2025 $20.49 $18.75 $26.70 +1,501%
November, 2025 $29.49 $18.81 $30.88 +2,204%
December, 2025 $34.09 $27.58 $40.72 +2,564%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2026

The predicted value for Fate Therapeutics Inc (FATE) in 2026 is set at an average of $71.82. Estimates vary from a peak of $111.27 to a trough of $32.37, indicating an +5,511% surge from the present price of $1.28.
Month Average Low High Change from today's price
January, 2026 $47.75 $32.37 $48.79 +3,631%
February, 2026 $83.47 $46.38 $93.63 +6,421%
March, 2026 $103.70 $74.24 $111.27 +8,001%
April, 2026 $100.46 $70.69 $109.99 +7,748%
May, 2026 $80.71 $63.35 $98.34 +6,205%
June, 2026 $68.55 $59.00 $85.78 +5,255%
July, 2026 $67.43 $59.00 $85.62 +5,168%
August, 2026 $80.62 $55.96 $81.86 +6,198%
September, 2026 $81.49 $69.91 $86.39 +6,266%
October, 2026 $86.67 $64.91 $87.18 +6,671%
November, 2026 $64.57 $58.01 $88.64 +4,944%
December, 2026 $50.82 $50.40 $67.77 +3,870%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Fate Therapeutics Inc (FATE) is $34.30, with a high forecast of $58.53 and a low forecast of $10.07. This indicates an +2,580% increase from the last price of $1.28.
Month Average Low High Change from today's price
January, 2027 $50.63 $46.08 $55.31 +3,855%
February, 2027 $47.73 $44.12 $56.88 +3,629%
March, 2027 $50.70 $35.54 $51.63 +3,861%
April, 2027 $35.36 $32.41 $58.53 +2,662%
May, 2027 $31.12 $25.64 $36.11 +2,332%
June, 2027 $24.86 $22.46 $34.61 +1,842%
July, 2027 $31.29 $21.86 $35.59 +2,345%
August, 2027 $27.29 $26.62 $35.71 +2,032%
September, 2027 $16.41 $13.26 $28.87 +1,182%
October, 2027 $14.01 $10.07 $18.04 +994.75%
November, 2027 $23.12 $14.38 $24.60 +1,706%
December, 2027 $27.10 $20.14 $30.41 +2,017%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2028

In 2028, Fate Therapeutics Inc (FATE) is projected to reach an average price of $15.04, with a high projection of $30.07 and a low estimate of $0.00614. This indicates an +1,075% rise from the last price of $1.28.
Month Average Low High Change from today's price
January, 2028 $20.14 $18.44 $30.07 +1,474%
February, 2028 $15.97 $14.56 $22.91 +1,148%
March, 2028 $14.65 $12.16 $17.54 +1,045%
April, 2028 $13.70 $12.34 $17.80 +970.33%
May, 2028 $5.0528 $4.9328 $15.41 +294.75%
June, 2028 $0.3491 $0.3691 $5.5518 -72.73%
July, 2028 $0.539 $0.0951 $1.399 -57.89%
August, 2028 $0.6284 $0.108 $1.4456 -50.90%
September, 2028 $0.4796 $0.0696 $0.5196 -62.53%
October, 2028 $0.4477 $0.1142 $1.4353 -65.02%
November, 2028 $0.1903 $0.1887 $0.5163 -85.13%
December, 2028 $0.1616 $0.00614 $0.9693 -87.37%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2029

The 2029 price forecast for Fate Therapeutics Inc Stock (FATE) is $4.2863 on average, with a high prediction of $8.42 and a low estimate of $0.1526. This represents an +234.87% increase from the previous price of $1.28.
Month Average Low High Change from today's price
January, 2029 $0.619 $0.1526 $0.449 -51.64%
February, 2029 $1.981 $1.1045 $1.781 +54.76%
March, 2029 $2.2729 $2.0219 $1.9029 +77.57%
April, 2029 $2.6348 $2.3384 $2.4248 +105.84%
May, 2029 $2.1022 $2.2522 $2.3913 +64.24%
June, 2029 $1.3741 $1.7241 $1.5227 +7.36%
July, 2029 $0.1461 $0.4561 $1.2796 -88.59%
August, 2029 $2.4465 $0.237 $2.9264 +91.13%
September, 2029 $3.3846 $1.6476 $4.1301 +164.42%
October, 2029 $3.2072 $3.1291 $5.3581 +150.56%
November, 2029 $1.5253 $1.4303 $4.2817 +19.16%
December, 2029 $9.185 $0.5098 $8.42 +617.58%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2030

Fate Therapeutics Inc Stock (FATE) is expected to reach an average price of $5.0473 in 2030, with a high forecast of $9.8141 and a low forecast of $0.2806. This signifies an +294.32% surge from the last price of $1.28.
Month Average Low High Change from today's price
January, 2030 $8.3998 $7.2429 $7.9123 +556.24%
February, 2030 $4.2987 $5.8077 $5.3067 +235.83%
March, 2030 $5.3125 $3.8616 $3.0716 +315.04%
April, 2030 $9.0464 $8.1054 $7.8364 +606.75%
May, 2030 $9.4812 $8.0183 $9.1912 +640.72%
June, 2030 $9.8151 $10.91 $9.8141 +666.80%
July, 2030 $10.05 $9.747 $9.4599 +685.15%
August, 2030 $3.7737 $5.3337 $8.9408 +194.82%
September, 2030 $2.0476 $4.5947 $3.9566 +59.97%
October, 2030 $5.3776 $0.2806 $5.4576 +320.12%
November, 2030 $3.3963 $3.7057 $9.0647 +165.33%
December, 2030 $0.3898 $1.4592 $4.8688 -69.55%
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):